Danielle Antalffy
Stock Analyst at UBS
(3.58)
# 821
Out of 5,127 analysts
198
Total ratings
48.25%
Success rate
6.62%
Average return
Main Sectors:
Stocks Rated by Danielle Antalffy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintains: Buy | $140 → $120 | $74.12 | +61.90% | 15 | Feb 5, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintains: Sell | $88 → $86 | $89.73 | -4.16% | 7 | Jan 28, 2026 | |
| EW Edwards Lifesciences | Maintains: Neutral | $92 → $95 | $76.80 | +23.70% | 14 | Jan 12, 2026 | |
| SGHT Sight Sciences | Maintains: Buy | $7 → $12 | $5.94 | +102.02% | 3 | Dec 23, 2025 | |
| INSP Inspire Medical Systems | Maintains: Neutral | $89 → $91 | $66.33 | +37.19% | 8 | Dec 23, 2025 | |
| GKOS Glaukos | Maintains: Buy | $140 → $145 | $113.27 | +28.01% | 3 | Dec 23, 2025 | |
| PRCT PROCEPT BioRobotics | Initiates: Buy | $62 | $29.21 | +112.26% | 4 | Dec 12, 2025 | |
| MDT Medtronic | Maintains: Neutral | $95 → $102 | $101.65 | +0.34% | 12 | Nov 19, 2025 | |
| PODD Insulet | Upgrades: Buy | $355 → $400 | $245.57 | +62.89% | 13 | Nov 19, 2025 | |
| TMCI Treace Medical Concepts | Maintains: Neutral | $6.5 → $5.85 | $2.21 | +164.71% | 8 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $16 | $15.12 | +5.82% | 5 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $106 → $95 | $70.16 | +35.40% | 10 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $24 → $21 | $21.73 | -3.36% | 7 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $585 → $600 | $492.84 | +21.74% | 3 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $214 | $238.64 | -10.33% | 6 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $8 | $8.26 | -3.15% | 4 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $57 | $22.36 | +154.92% | 2 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $18.89 | -10.01% | 15 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $36.94 | +57.03% | 13 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $146 → $148 | $111.07 | +33.25% | 12 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $366 → $370 | $356.08 | +3.91% | 6 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $2.25 | $3.33 | -32.43% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $975 → $825 | $4.65 | +17,641.94% | 2 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $14 | $33.93 | -58.74% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $100 | $65.21 | +53.35% | 2 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $12 | $15.25 | -21.31% | 3 | Mar 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $40 → $45 | $35.25 | +27.66% | 4 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $270 → $275 | $207.39 | +32.60% | 1 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $26 → $20 | $3.83 | +422.19% | 3 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $72 → $42 | $5.58 | +652.69% | 7 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $60 | $8.04 | +646.27% | 3 | Apr 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $15 | $0.67 | +2,135.47% | 1 | Sep 1, 2020 |
Boston Scientific
Feb 5, 2026
Maintains: Buy
Price Target: $140 → $120
Current: $74.12
Upside: +61.90%
Zimmer Biomet Holdings
Jan 28, 2026
Maintains: Sell
Price Target: $88 → $86
Current: $89.73
Upside: -4.16%
Edwards Lifesciences
Jan 12, 2026
Maintains: Neutral
Price Target: $92 → $95
Current: $76.80
Upside: +23.70%
Sight Sciences
Dec 23, 2025
Maintains: Buy
Price Target: $7 → $12
Current: $5.94
Upside: +102.02%
Inspire Medical Systems
Dec 23, 2025
Maintains: Neutral
Price Target: $89 → $91
Current: $66.33
Upside: +37.19%
Glaukos
Dec 23, 2025
Maintains: Buy
Price Target: $140 → $145
Current: $113.27
Upside: +28.01%
PROCEPT BioRobotics
Dec 12, 2025
Initiates: Buy
Price Target: $62
Current: $29.21
Upside: +112.26%
Medtronic
Nov 19, 2025
Maintains: Neutral
Price Target: $95 → $102
Current: $101.65
Upside: +0.34%
Insulet
Nov 19, 2025
Upgrades: Buy
Price Target: $355 → $400
Current: $245.57
Upside: +62.89%
Treace Medical Concepts
Nov 7, 2025
Maintains: Neutral
Price Target: $6.5 → $5.85
Current: $2.21
Upside: +164.71%
Nov 6, 2025
Maintains: Neutral
Price Target: $16 → $16
Current: $15.12
Upside: +5.82%
Nov 3, 2025
Maintains: Buy
Price Target: $106 → $95
Current: $70.16
Upside: +35.40%
Oct 31, 2025
Maintains: Neutral
Price Target: $24 → $21
Current: $21.73
Upside: -3.36%
Oct 23, 2025
Maintains: Neutral
Price Target: $585 → $600
Current: $492.84
Upside: +21.74%
Oct 14, 2025
Maintains: Buy
Price Target: $190 → $214
Current: $238.64
Upside: -10.33%
Aug 8, 2025
Maintains: Neutral
Price Target: $16 → $8
Current: $8.26
Upside: -3.15%
Aug 8, 2025
Maintains: Buy
Price Target: $65 → $57
Current: $22.36
Upside: +154.92%
Aug 7, 2025
Maintains: Neutral
Price Target: $20 → $17
Current: $18.89
Upside: -10.01%
Apr 30, 2025
Maintains: Buy
Price Target: $60 → $58
Current: $36.94
Upside: +57.03%
Jan 23, 2025
Maintains: Buy
Price Target: $146 → $148
Current: $111.07
Upside: +33.25%
Oct 30, 2024
Maintains: Neutral
Price Target: $366 → $370
Current: $356.08
Upside: +3.91%
Mar 29, 2023
Initiates: Neutral
Price Target: $2.25
Current: $3.33
Upside: -32.43%
May 5, 2022
Maintains: Outperform
Price Target: $975 → $825
Current: $4.65
Upside: +17,641.94%
May 5, 2022
Maintains: Outperform
Price Target: $12 → $14
Current: $33.93
Upside: -58.74%
May 2, 2022
Maintains: Outperform
Price Target: $75 → $100
Current: $65.21
Upside: +53.35%
Mar 11, 2022
Maintains: Outperform
Price Target: $15 → $12
Current: $15.25
Upside: -21.31%
Feb 25, 2022
Maintains: Outperform
Price Target: $40 → $45
Current: $35.25
Upside: +27.66%
Feb 4, 2022
Maintains: Market Perform
Price Target: $270 → $275
Current: $207.39
Upside: +32.60%
Nov 10, 2021
Maintains: Outperform
Price Target: $26 → $20
Current: $3.83
Upside: +422.19%
Nov 5, 2021
Maintains: Market Perform
Price Target: $72 → $42
Current: $5.58
Upside: +652.69%
Apr 1, 2021
Downgrades: Market Perform
Price Target: $60
Current: $8.04
Upside: +646.27%
Sep 1, 2020
Initiates: Outperform
Price Target: $15
Current: $0.67
Upside: +2,135.47%